Daily Movers: Welcoming Fitbit; BioMarin Soars Again, While Oracle Slumps

Thursday’s market session contained many exciting stock movements.

Gainers

Fitbit Inc FIT was introduced to the New York Stock Exchange, opening at the price of $30.20, representing a 52 percent spike.

Kroger Co KR reported earnings that were better-than-expected, although it missed analyst estimates on revenues. Kroger was up about 1 percent.

Synergy Pharmaceuticals Inc SGYP was soaring nearly 8 percent due analyst increased target expectations alongside the positive phase III data.

BioMarin Pharmaceutical Inc BMRN surged 12 percent due to three key factors; good news on the drug associated to the genetic mutation that causes dwarfism, strong analyst support and the NASDAQ  approached an all-time high.

Radius Health Inc RDUS skyrocketed to $60.33, from $51.73 (17 percent increase). The catalyst was the announcement of positive top-line data associated from ACTIVExtend trial results.

Lumenis Ltd. LMNS spiked 13 percent, from $12.68 to $13.69, as the company agreed to be purchased for $14 per share by XIO Group.

Losers

Oracle Corporation (NYSE; ORCL) tanked as much as 8 percent due to disappointing earnings results. The tech giant missed fourth quarter profits by $0.08 along with revenues dropping more than 5 percent.

Rite Aid Corporation RAD dropped as low as 6 percent due to unsatisfied earnings or $0.02 per share, down from $0.04 per share from last year.

Ensco plc ESV declined nearly 5 percent on the agreement it made to reduce the rate it charged Total S.A. TOT due to rising oil prices.

Jabil Circuit, Inc. JBL declined 7 percent to $22.61 on lower earnings estimates from Deutsche Bank. Deutsche lowered its full-year earnings for JBL from $1.68 to $1.63 after the company reported earnings of $0.49 per share.